Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
达雷妥尤单抗、来那度胺、硼替佐米和地塞米松联合治疗适合移植的新诊断多发性骨髓瘤:GRIFFIN试验
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2020005288
Voorhees, Peter M; Kaufman, Jonathan L; Laubach, Jacob; Sborov, Douglas W; Reeves, Brandi; Rodriguez, Cesar; Chari, Ajai; Silbermann, Rebecca; Costa, Luciano J; Anderson, Larry D Jr; Nathwani, Nitya; Shah, Nina; Efebera, Yvonne A; Holstein, Sarah A; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M; Orlowski, Robert Z; Shain, Kenneth H; Cowan, Andrew J; Murphy, Sean; Lutska, Yana; Pei, Huiling; Ukropec, Jon; Vermeulen, Jessica; de Boer, Carla; Hoehn, Daniela; Lin, Thomas S; Richardson, Paul G